Prognostic value of initial KL-6 (Krebs von den Lungen 6) plasma level during COVID-19 pneumonia

被引:0
|
作者
Letellier, A.
Rolland-Debord, C.
Paz, D. Luque
Lefevre, G. [1 ]
Pieroni, L. [1 ]
Parrot, A.
Cadranel, J.
机构
[1] Sorbonne Univ, Dept Pneumol, AP HP Hop Tenon, Paris, France
关键词
D O I
10.1183/13993003.congress-2022.2540
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
2540
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumonia
    Letellier, Alice
    Rolland-Debord, Camille
    Luque-Paz, David
    Milon, Audrey
    Choinier, Pascaline
    Blin, Emmanuelle
    Halitim, Pierre
    Bravais, Juliette
    Lefevre, Guillaume
    Parrot, Antoine
    Pieroni, Laurence
    Cadranel, Jacques
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2023, 84
  • [2] Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality
    Scarpati G.
    Baldassarre D.
    Boffardi M.
    Calabrese V.
    De Robertis E.
    Lacava G.
    Oliva F.
    Pagliano P.
    Pascale G.
    Tripepi G.L.
    Piazza O.
    [J]. Journal of Anesthesia, Analgesia and Critical Care, 2 (1):
  • [3] Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
    Stockhammer, Paul
    Baumeister, Hannah
    Ploenes, Till
    Bonella, Francesco
    Theegarten, Dirk
    Dome, Balazs
    Pirker, Christine
    Berger, Walter
    Hegedues, Luca
    Baranyi, Marcell
    Schuler, Martin
    Deshayes, Sophie
    Bolukbas, Servet
    Aigner, Clemens
    Blanquart, Christophe
    Hegedues, Balazs
    [J]. LUNG CANCER, 2023, 185
  • [4] Secukinumab decreases serum Krebs von den Lungen 6 (KL-6) level in patients with psoriasis with elevated serum KL-6 level
    Chijiwa, C.
    Takeoka, S.
    Kamata, M.
    Uchida, H.
    Fukaya, S.
    Hayashi, K.
    Fukuyasu, A.
    Tanaka, T.
    Ishikawa, T.
    Ohnishi, T.
    Tada, Y.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (06) : 1396 - 1397
  • [5] Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-Analysis
    Matuszewski, Michal
    Szarpak, Lukasz
    Rafique, Zubaid
    Peacock, Frank W.
    Pruc, Michal
    Szwed, Piotr
    Chirico, Francesco
    Navolokina, Alla
    Ladny, Jerzy R.
    Denegri, Andrea
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [6] Association of Serum Krebs von den Lungen-6 (KL-6) Levels and Disease Severity in Patients Hospitalized with COVID-19
    Evlice, Oguz
    Bektas, Murat
    Kar, Fatih
    Marim, Feride
    Kaya, Ilknur
    Yorukoglu, Kerem
    Ak, Oznur
    [J]. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2023, 5 (04): : 292 - 299
  • [7] EXPLORING THE ROLE OF KREBS VON DEN LUNGEN-6 (KL-6) IN SEVERE TO CRITICAL COVID-19: A SINGLE INSTITUTION EXPERIENCE
    Perrotta, F.
    D'Agnano, V
    Scialo, F.
    Cerqua, F. S.
    Aronne, L.
    Atripaldi, L.
    Iadevaia, C.
    Mazzeo, G.
    Costigliola, A.
    Bianco, A.
    Calabrese, C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [8] Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis
    Mostafa, Amira Ismail
    Salem, Ayman Elsayed
    Ahmed, Heba Allah Moussa
    Bayoumi, Aml Ibrahim
    Halim, Radwa M. Abdel
    Samie, Rasha M. Abdel
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2021, 84 (03) : 200 - 208
  • [9] Serum Krebs von den Lungen-6 (KL-6) level as a prognostic biomarker in patients with interstitial lung abnormalities (ILA)
    Park, Hye Kyeong
    Yoon, Young-Soon
    Song, Jae-Uk
    Kang, Hyung Koo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses
    Naderi, Nadereh
    Rahimzadeh, Mahsa
    [J]. VIROLOGY, 2022, 566 : 106 - 113